Recent insights on the putative role of autophagy in autoimmune diseases

Autoimmunity Reviews

Volumn 13, Issue 3, 2014, Pages 231-241

  Gianchecchi, Elena ^a   Delfino, Domenico Vittorio ^b   Fierabracci, Alessandra ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Autoimmunity; Autophagy; Candidate autoimmune genes; Etiopathogenesis; Innate adaptive immune system

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THYMOCYTE ANTIBODY;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOPHAGY; B LYMPHOCYTE; CELL FUNCTION; CHAPERONE-MEDIATED AUTOPHAGY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; EPITHELIUM CELL; EUKARYOTIC CELL; GENETIC ASSOCIATION; HUMAN; INFECTION SENSITIVITY; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; LYSOSOME; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOCYTE; VITILIGO;

AUTOIMMUNITY; AUTOPHAGY; CANDIDATE AUTOIMMUNE GENES; ETIOPATHOGENESIS; INNATE/ADAPTIVE IMMUNE SYSTEM;

ANIMALS; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASES; AUTOPHAGY; CELL DIFFERENTIATION; HUMANS; POLYMORPHISM, GENETIC; T-LYMPHOCYTES;

EID: 84891746273     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.10.007     Document Type: Review

References (150)

1. Sadovnick A.D. Genetic background of multiple sclerosis. Autoimmun Rev 2012, 11:163-166.
2. Shapira Y., Agmon-Levin N., Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010, 34:168-177.
3. Tobón G.J., Pers J.O., Cañas C.A., Rojas-Villarraga A., Youinou P., Anaya J.M. Are autoimmune diseases predictable?. Autoimmun Rev 2012, 11:259-266.
4. Fierabracci A., Milillo A., Locatelli D.F., Fruci D. The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genome-wide association studies. Autoimmun Rev 2012, 12:281-288.
5. Fierabracci A. Unravelling the role of infectious agents in the pathogenesis of human autoimmunity: the hypothesis of the retroviral involvement revisited. Curr Mol Med 2009, 9:1024-1033.
6. Chang H.D., Radbruch A. Targeting pathogenic T helper cell memory. Ann Rheum Dis 2011, 70:i85-i87.
7. Nagafuchi S. The role of B cells in regulating the magnitude of immune response. Microbiol Immunol 2010, 54:487-490.
8. Lessard C.J., Ice J.A., Adrianto I., Wliley G.B., Kelly J.A., Gaffney P.M., et al. The genomics of autoimmune disease in the era of genome-wide association studies and beyond. Autoimmun Rev 2012, 11267-11275.
9. Gianchecchi E., Palombi M., Fierabracci A. The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity. Autoimmun Rev 2013, 12:717-725.
10. Park C., Cuervo A.M. Selective autophagy: talking with the UPS. Cell Biochem Biophys 2013, 67:3-13.
11. Neefjes J., Jongsma M.L., Paul P., Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 2011, 11:823-836.
12. Pierdominici M., Vomero M., Barbati C., Colasanti T., Maselli A., Vacirca D., et al. Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus. FASEB J 2012, 26:1400-1412.
13. Puleston D.J., Simon A.K. Autophagy in the immune system. Immunology 2013, 10.1111/imm.12165.
14. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
15. Lapaquette P., Brest P., Hofman P., Darfeuille-Michaud A. Etiology of Crohn's disease: many roads lead to autophagy. J Mol Med 2012, 90:987-996.
16. Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290:1717-1721.
17. Oh J.E., Lee H.K. Autophagy as an innate immune modulator. Immune Netw 2013, 13:1-9.
18. Maes H., Rubio N., Garg A.D., Agostinis P. Autophagy: shaping the tumor microenvironment and therapeutic response. Trends Mol Med 2013, 19:428-446.
19. Rubinsztein D.C., Codogno P., Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 2012, 11:709-730.
20. Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature 2011, 469:323-335.
21. Lleo A., Invernizzi P., Selmi C., Coppel R.L., Alpini G., Podda M., et al. Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun 2007, 29:61-68.
22. Alessandri C., Barbati C., Vacirca D., Piscopo P., Confaloni A., Sanchez M., et al. T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy. FASEB J 2012, 26:4722-4732.
23. Chen Y., Klionsky D.J. The regulation of autophagy - unanswered questions. J Cell Sci 2011, 124:161-170.
24. Wirawan E., Vanden Berghe T., Lippens S., Agostinis P., Vandenabeele P. Autophagy: for better or for worse. Cell Res 2012, 22:43-61.
25. Liang J., Shao S.H., Xu Z.X., Hennessy B., Ding Z., Larrea M., et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007, 9:218-224.
26. Sakaki K., Wu J., Kaufman R.J. Protein kinase Ctheta is required for autophagy in response to stress in the endoplasmic reticulum. J Biol Chem 2008, 283:15370-15380.
27. Zhang H., Bosch-Marce M., Shimoda L.A., Tan Y.S., Baek J.H., Wesley J.B., et al. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 2008, 283:10892-10903.
28. Bjørkøy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005, 171:603-614.
29. Yu L., McPhee C.K., Zheng L., Mardones G.A., Rong Y., Peng J., et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465:942-946.
30. Hubbard V.M., Valdor R., Patel B., Singh R., Cuervo A.M., Macian F. Macroautophagy regulates energy metabolism during effector T cell activation. J Immunol 2010, 185:7349-7357.
31. Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004, 119:753-766.
32. Miller B.C., Zhao Z., Stephenson L.M., Cadwell K., Pua H.H., Lee H.K., et al. The autophagy gene ATG5 plays an essential role in B lymphocyte development. Autophagy 2008, 4:309-314.
33. Kuma A., Hatano M., Matsui M., Yamamoto A., Nakaya H., Yoshimori T., et al. The role of autophagy during the early neonatal starvation period. Nature 2004, 432:1032-1036.
34. Cuervo A.M., Dice J.F. When lysosomes get old. Exp Gerontol 2000, 35:119-131.
35. Wullschleger S., Loewith R., Hall M.N. TOR signaling in growth and metabolism. Cell 2006, 124:471-484.
36. Mordier S., Deval C., Bechet D., Tassa A., Ferrara M. Leucine limitation induces autophagy and activation of lysosome-dependent proteolysis in C2C12 myotubes through a mammalian target of rapamycin-independent signaling pathway. J Biol Chem 2000, 275:29900-29906.
37. Rubinsztein D.C., Gestwicki J.E., Murphy L.O., Klionsky D.J. Potential therapeutic applications of autophagy. Nat Rev Drug Discov 2007, 6:304-312.
38. Jia G., Cheng G., Gangahar D.M., Agrawal D.K. Insulin-like growth factor-1 and TNF-alpha regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells. Immunol Cell Biol 2006, 84:448-454.
39. Komatsu M., Waguri S., Ueno T., Iwata J., Murata S., Tanida I., et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 2005, 169:425-434.
40. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441:885-889.
41. Komatsu M., Wang Q.J., Holstein G.R., Friedrich V.L., Iwata J., Kominami E., et al. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc Natl Acad Sci U S A 2007, 104:14489-14494.
42. Nedjic J., Aichinger M., Klein L. A novel role for autophagy in T cell education. Autophagy 2008, 4:1090-1092.
43. Levine B., Klionsky D.J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004, 6:463-477.
44. Shintani T., Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 2004, 306:990-995.
45. Bhattacharya A., Eissa N.T. Autophagy and autoimmunity crosstalks. Front Immunol 2013, 4:88.
46. Saitoh T., Akira S. Regulation of innate immune responses by autophagy-related proteins. J Cell Biol 2010, 189:925-935.
47. Gros F., Arnold J., Page N., Décossas M., Korganow A.S., Martin T., et al. Macroautophagy is deregulated in murine and human lupus T lymphocytes. Autophagy 2012, 8:1113-1123.
48. Espert L., Denizot M., Grimaldi M., Robert-Hebmann V., Gay B., Varbanov M., et al. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest 2006, 116:2161-2172.
49. Pua H.H., Dzhagalov I., Chuck M., Mizushima N., He Y.W. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med 2007, 204:25-31.
50. Arsov I., Adebayo A., Kucerova-Levisohn M., Haye J., MacNeil M., Papavasiliou F.N., et al. A role for autophagic protein beclin 1 early in lymphocyte development. J Immunol 2011, 186:2201-2209.
51. Schmid D., Pypaert M., Münz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007, 26:79-92.
52. Levine B., Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 2007, 7:767-777.
53. Brazil M.I., Weiss S., Stockinger B. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules. Eur J Immunol 1997, 27:1506-1514.
54. Nimmerjahn F., Milosevic S., Behrends U., Jaffee E.M., Pardoll D.M., Bornkamm G.W., et al. Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur J Immunol 2003, 33:1250-1259.
55. Paludan C., Schmid D., Landthaler M., Vockerodt M., Kube D., Tuschl T., et al. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 2005, 307:593-596.
56. Mizushima N., Yamanoto A., Matsui M., Yoshonori T., Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004, 15:1101-1111.
57. Kasai M., Tanida I., Ueno T., Kominami E., Seki S., Ikeda T., et al. Autophagic compartments gain access to the MHC class II compartments in thymic epithelium. J Immunol 2009, 183:7278-7285.
58. Dengjel J., Schoor O., Fischer R., Reich M., Kraus M., Müller M., et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci U S A 2005, 102:7922-7927.
59. Aichinger M., Wu C., Nedjic J., Klein L. Macroautophagy substrates are loaded onto MHC class II of medullary thymic epithelial cells for central tolerance. J Exp Med 2013, 210:287-300.
60. Hubbard V.M., Valdor R., Patel B., Singh R., Cuervo A.M., Macian F. Macroautophagy regulates energy metabolism during effector T cell activation. J Immunol 2010, 185:7349-7357.
61. Nedjic J., Aichinger M., Emmerich J., Mizushima N., Klein L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 2008, 455:396-400.
62. Sukseree S., Mildner M., Rossiter H., Pammer J., Zhang C.F., Watanapokasin R., et al. Autophagy in the thymic epithelium is dispensable for the development of self-tolerance in a novel mouse model. PLoS One 2012, 7:e38933.
63. Caza T.N., Talaber G., Perl A. Metabolic regulation of organelle homeostasis in lupus T cells. Clin Immunol 2012, 144:200-213.
64. Pua H.H., He Y.W. Maintaining T lymphocyte homeostasis: another duty of autophagy. Autophagy 2007, 3:266-267.
65. Matsunaga K., Noda T., Yoshimori T. Binding Rubicon to cross the Rubicon. Autophagy 2009, 5:876-877.
66. Arsov I., Li X., Matthews G., Coradin J., Hartmann B., Simon A.K., et al. BAC-mediated transgenic expression of fluorescent autophagic protein Beclin 1 reveals a role for Beclin 1 in lymphocyte development. Cell Death Differ 2008, 15:1385-1395.
67. Stephenson L.M., Miller B.C., Ng A., Eisenberg J., Zhao Z., Cadwell K., et al. Identification of Atg5-dependent transcriptional changes and increases in mitochondrial mass in Atg5-deficient T lymphocytes. Autophagy 2009, 5:625-635.
68. Pua H.H., Guo J., Komatsu M., He Y.W. Autophagy is essential for mitochondrial clearance in mature T lymphocytes. J Immunol 2009, 182:4046-4055.
69. Jia W., He Y.W. Temporal regulation of intracellular organelle homeostasis in T lymphocytes by autophagy. J Immunol 2011, 186:5313-5322.
70. Jia W., Pua H.H., Li Q.J., He Y.W. Autophagy regulates endoplasmic reticulum homeostasis and calcium mobilization in T lymphocytes. J Immunol 2011, 186:1564-1574.
71. Lioudyno M.I., Kozak J.A., Penna A., Safrina O., Zhang S.L., Sen D., et al. Orai1 and STIM1 move to the immunological synapse and are up-regulated during T cell activation. Proc Natl Acad Sci U S A 2008, 105:2011-2016.
72. Yue Z., Jin S., Yang C., Levine A.J., Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003, 100:15077-15082.
73. Qu X., Yu J., Bhagat G., Furuya N., Hibshoosh H., Troxel A., et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003, 112:1809-1820.
74. Ogawa M., Yoshimori T., Suzuki T., Sagara H., Mizushima N., Sasakawa C. Escape of intracellular Shigella from autophagy. Science 2005, 307:727-731.
75. Wright K., Ward S.G., Kolios G., Westwick J. Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J Biol Chem 1997, 272:12626-12633.
76. Yuk J.M., Shin D.M., Lee H.M., Yang C.S., Jin H.S., Kim K.K., et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009, 6:231-243.
77. Sanjuan M.A., Dillon C.P., Tait S.W., Moshiach S., Dorsey F., Connell S., et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007, 450:1253-1257.
78. Yordy B., Iwasaki A. Autophagy in the control and pathogenesis of viral infection. Curr Opin Virol 2011, 1:196-203.
79. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
80. Shi C.S., Shenderov K., Huang N.N., Kabat J., Abu-Asab M., Fitzgerald K.A., et al. Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012, 13:255-263.
81. Bodemann B.O., Orvedahl A., Cheng T., Ram R.R., Ou Y.H., Formstecher E., et al. RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell 2011, 144:253-267.
82. Johansen T., Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011, 7:279-296.
83. Jia K., Thomas C., Akbar M., Sun Q., Adams-Huet B., Gilpin C., et al. Autophagy genes protect against Salmonella typhimurium infection and mediate insulin signaling-regulated pathogen resistance. Proc Natl Acad Sci U S A 2009, 106:14564-14569.
84. Shelly S., Lukinova N., Bambina S., Berman A., Cherry S. Autophagy is an essential component of Drosophila immunity against vesicular stomatitis virus. Immunity 2009, 30:588-598.
85. Yano T., Mita S., Ohmori H., Oshima Y., Fujimoto Y., Ueda R., et al. Autophagic control of listeria through intracellular innate immune recognition in drosophila. Nat Immunol 2008, 9:908-916.
86. Zhao Z., Fux B., Goodwin M., Dunay I.R., Strong D., Miller B.C., et al. Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe 2008, 4:458-469.
87. Orvedahl A., MacPherson S., Sumpter R., Tallóczy Z., Zou Z., Levine B. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe 2010, 7:115-127.
88. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007, 39:596-604.
89. Birmingham C.L., Smith A.C., Bakowski M.A., Yoshimori T., Brumell J.H. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol Chem 2006, 281:11374-11383.
90. Messer J.S., Murphy S.F., Logsdon M.F., Lodolce J.P., Grimm W.A., Bartulis S.J., et al. The Crohn's disease: associated ATG16L1 variant and Salmonella invasion. BMJ 2013, 3. [pii: e002790]. 10.1136/bmjopen-2013-002790.
91. Raju D., Hussey S., Jones N.L. Crohn disease ATG16L1 polymorphism increases susceptibility to infection with Helicobacter pylori in humans. Autophagy 2012, 8:1387-1388.
92. Songane M., Kleinnijenhuis J., Alisjahbana B., Sahiratmadja E., Parwati I., Oosting M., et al. Polymorphisms in autophagy genes and susceptibility to tuberculosis. PLoS One 2012, 7:e41618. 10.1371/journal.pone.0041618.
93. Bahari G., Hashemi M., Taheri M., Naderi M., Eskandari-Nasab E., Atabaki M. Association of IRGM polymorphisms and susceptibility to pulmonary tuberculosis in Zahedan, Southeast Iran. Sci World J 2012, 2012:950801.
94. Intemann C.D., Thye T., Niemann S., Browne E.N., Amanua Chinbuah M., Enimil A., et al. Autophagy gene variant IRGM-261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog 2009, 5:e1000577.
95. Che N., Li S., Gao T., Zhang Z., Han Y., Zhang X., et al. Identification of a novel IRGM promoter single nucleotide polymorphism associated with tuberculosis. Clin Chim Acta 2010, 411:1645-1649.
96. King K.Y., Lew J.D., Ha N.P., Lin J.S., Ma X., Graviss E.A., et al. Polymorphic allele of human IRGM1 is associated with susceptibility to tuberculosis in African Americans. PLoS One 2011, 6:e16317. 10.1371/journal.pone.0016317.
97. Towns R., Kabeya Y., Yoshimori T., Guo C., Shangguan Y., Hong S., et al. Sera from patients with type 2 diabetes and neuropathy induce autophagy and colocalization with mitochondria in SY5Y cells. Autophagy 2005, 1:163-170.
98. Perl A., Gergely P., Nagy G., Koncz A., Banki K. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol 2004, 25:360-367.
99. Nagy G., Koncz A., Perl A. T cell activation-induced mitochondrial hyperpolarization is mediated by Ca2+- and redox-dependent production of nitric oxide. J Immunol 2003, 171:5188-5197.
100. Kis-Toth K., Tsokos G.C. Dendritic cell function in lupus: independent contributors or victims of aberrant immune regulation. Autoimmunity 2010, 43:121-130.
101. Monneaux F., Muller S. Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects. Arthritis Res Ther 2009, 11:234.
102. Perl A. Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. Curr Opin Rheumatol 2009, 21:443-447.
103. Ruiz-Irastorza G., Ramos-Casals M., Brito-Zeron P., Khamashta M.A. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010, 69:20-28.
104. Page N., Gros F., Schall N., Décossas M., Bagnard D., Briand J.-P., et al. HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus. Ann Rheum Dis 2011, 70:837-843.
105. Page N., Gros F., Schall N., Briand J.P., Muller S. A therapeutic peptide in lupus alters autophagic processes and stability of MHCII molecules in MRL/lpr B cells. Autophagy 2011, 7:539-540.
106. Orozco G., Eyre S., Hinks A., Bowes J., Morgan A.W., Wilson A.G., et al. Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 2011, 70:463-468.
107. Gateva V., Sandling J.K., Hom G., Taylor K.E., Chung S.A., Sun X., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41:1228-1233.
108. Loftus E.V. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004, 126:1504-1517.
109. Lees C.W., Barrett J.C., Parkes M., Satsangi J. New IBD genetics: common pathways with other diseases. Gut 2011, 60:1739-1753.
110. Muzes G., Tulassay Z., Sipos F. Interplay of autophagy and innate immunity in Crohn's disease: a key immunobiologic feature. World J Gastroenterol 2013, 19:4447-4454.
111. Cadwell K., Liu J.Y., Brown S.L., Miyoshi H., Loh J., Lennerz J.K., et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008, 456:259-263.
112. Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature 2011, 469:323-335.
113. Porter E.M., Bevins C.L., Ghosh D., Ganz T. The multifaceted Paneth cell. Cell Mol Life Sci 2002, 59:156-170.
114. Umeno J., Asano K., Matsushita T., MatsumotoT KiyoharaY, Iida M., et al. Meta-analysis of published studies identified eight additional common susceptibility loci for Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2011, 17:2407-2415.
115. Chatzikyriakidou A., Voulgari P.V., Drosos A.A. Lack of association of the autophagy-related gene polymorphism ATG16L1 rs2241880 in RA predisposition. Rheumatol Int 2013, 10.1007/s00296-013-2726-z.
116. Hampe J., Franke A., Rosenstiel P., Till A., Teuber M., Huse K., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007, 39:207-211.
117. Mizushima N., Kuma A., Kobayashi Y., Yamamoto A., Matsubae M., Takao T., et al. Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J Cell Sci 2003, 116:1679-1688.
118. Palomino-Morales R.J., Oliver J., Gomez-Garcia M., Lopez-Nevot M.A., Rodrigo L., Nieto A., et al. Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes Immun 2009, 10:356-364.
119. Lacher M., Schroepf S., Ballauff A., Lohse P., von Schweinitz D., Kappler R., et al. Autophagy 16-like 1 rs2241880 G allele is associated with Crohn's disease in German children. Acta Paediatr 2009, 98:1835-1840.
120. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962.
121. Durães C., Machado J.C., Portela F., Rodrigues S., Lago P., Cravo M., et al. Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II). Inflamm Bowel Dis 2013, 19:230-239.
122. Amre D.K., Mack D.R., Morgan K., Krupoves A., Costea I., Lambrette P., et al. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Inflamm Bowel Dis 2009, 15:501-507.
123. Glas J., Seiderer J., Bues S., Stallhofer J., Fries C., Olszak T., et al. IRGM variants and susceptibility to inflammatory bowel disease in the German population. PLoS One 2013, 8:e54338.
124. Latiano A., Palmieri O., Cucchiara S., Castro M., D'Inca R., Guariso G., et al. Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease. Am J Gastroenterol 2009, 104:110-116.
125. Roberts R.L., Hollis-Moffatt J.E., Gearry R.B., Kennedy M.A., Barclay M.L., Merriman T.R., et al. Confirmation of association of IRGM and NCF4 with ileal Crohn's disease in a population-based cohort. Genes Immun 2008, 9:561-565.
126. Moon C.M., Shin D.J., Kim S.W., Son N.H., Park A., Park B., et al. Associations between genetic variants in the IRGM gene and inflammatory bowel diseases in the Korean population. Inflamm Bowel Dis 2013, 19:106-114.
127. Inoue N., Tamura K., Kinouchi Y., Fukuda Y., Takahashi S., Ogura Y., et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002, 123:86-91.
128. Kim E.S., Kim W.H. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics. Gut Liver 2010, 4:1-14.
129. Anderson C.A., Boucher G., Lees C.W., Franke A., D'Amato M., Taylor K.D., et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011, 43:246-252.
130. Hirano A., Yamazaki K., Umeno J., Ashikawa K., Aoki M., Matsumoto T., et al. Association study of 71 European Crohn's disease susceptibility loci in a Japanese population. Inflamm Bowel Dis 2013, 19:526-533.
131. Prescott N.J., Dominy K.M., Kubo M., Lewis C.M., Fisher S.A., Redon R., et al. Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease. Hum Mol Genet 2010, 19:1828-1839.
132. Yamazaki K., Takahashi A., Takazoe M., Kubo M., Onouchi Y., Fujino A., et al. Positive association of genetic variants in the upstream region of NKX2-3 with Crohn's disease in Japanese patients. Gut 2009, 58:228-232.
133. Wang M.H., Okazaki T., Kugathasan S., Cho J.H., Isaacs K.L., Lewis J.D., et al. Contribution of higher risk genes and European admixture to Crohn's disease in African Americans. Inflamm Bowel Dis 2012, 18:2277-2287.
134. Lin N.Y., Beyer C., Giessl A., Kireva T., Scholtysek C., Uderhardt S., et al. Autophagy regulates TNFα-mediated joint destruction in experimental arthritis. Ann Rheum Dis 2013, 72:761-768.
135. Connor A.M., Mahomed N., Gandhi R., Keystone E.C., Berger S.A. TNFα modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 2012, 14:R62.
136. Shin Y.J., Han S.H., Kim D.S., Lee G.H., Yoo W.H., Kang Y.M., et al. Autophagy induction and CHOP under-expression promotes survival of fibroblasts from rheumatoid arthritis patients under endoplasmic reticulum stress. Arthritis Res Ther 2010, 12:R19.
137. Xu K., Xu P., Yao J.F., Zhang Y.G., Hou W.K., Lu S.M. Reduced apoptosis correlates with enhanced autophagy in synovial tissues of rheumatoid arthritis. Inflamm Res 2013, 62:229-237.
138. Ayroldi E., Bastianelli A., Cannarile L., Petrillo M.G., Delfino D.V., Fierabracci A. A pathogenetic approach to autoimmune skin disease therapy: psoriasis and biological drugs, unresolved issues, and future directions. Curr Pharm Des 2011, 17:3176-3190.
139. Asumalahti K., Ameen M., Suomela S., Hagforsen E., Michaëlsson G., Evans J., et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol 2003, 120:627-632.
140. Douroudis K., Kingo K., Traks T., Reimann E., Raud K., Rätsep R., et al. Polymorphisms in the ATG16L1 gene are associated with psoriasis vulgaris. Acta Derm Venereol 2012, 92:85-87.
141. Zhernakova A., Withoff S., Wijmenga C. Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat Rev Endocrinol 2013, 10.1038/nrendo.2013.161.
142. Wenink M.H., Santegoets K.C., Butcher J., van Bon L., Lamers-Karnebeek F.G., van den Berg W.B., et al. Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis. Arthritis Rheum 2011, 63:3313-3322.
143. Douroudis K., Kingo K., Traks T., Rätsep R., Silm H., Vasar E., et al. ATG16L1 gene polymorphisms are associated with palmoplantar pustulosis. Hum Immunol 2011, 72:613-615.
144. Kovacs S.O. Vitiligo. J Am Acad Dermatol 1998, 38:647-666.
145. Jeong T.J., Shin M.K., Uhm Y.K., Kim H.J., Chung J.H., Lee M.H. Association of UVRAG polymorphisms with susceptibility to non-segmental vitiligo in a Korean sample. Exp Dermatol 2010, 19:e323-e325.
146. Liang C., Feng P., Ku B., Dotan I., Canaani D., Oh B.H., et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 2006, 8:688-699.
147. Perelman B., Dafni N., Naiman T., Eli D., Yaakov M., Feng T.L., et al. Molecular cloning of a novel human gene encoding a 63-kDa protein and its sublocalization within the 11q13 locus. Genomics 1997, 41:397-405.
148. Trapp B.D., Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu Rev Neurosci 2008, 31:247-269.
149. Alirezaei M., Fox H.S., Flynn C.T., Moore C.S., Hebb A.L., Frausto R.F., et al. Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis. Autophagy 2009, 5:152-158.
150. Xu H., Wu Z.Y., Fang F., Guo L., Chen D., Chen J.X., et al. Genetic deficiency of Irgm1 (LRG-47) suppresses induction of experimental autoimmune encephalomyelitis by promoting apoptosis of activated CD4+ T cells. FASEB J 2010, 24:1583-1592.